Lifeboat Foundation

• In 2016 alone, 58,320 people in the U.S. died from leukemia. This new development could increase a patients’ chance of survival
• Current treatment methods can increase a patient’s risk of secondary cancer after remission. This Engineered T-Cell approach has not shown to be carcinogenic

Wouldn’t it be wonderful if the need for chemotherapy no longer existed? In some cases, these treatments aren’t even effective enough to send patients into remission, but for many people, there are few other options.

What if there was an easier and more effective way to tackle cancer? Thanks to one recent case, there is.